(ACI) Albertsons Companies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0130911037
Stock: Groceries, Pharmacy, Fuel, General Merchandise, Processed Foods
Total Rating 24
Risk 63
Buy Signal -1.74
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -2.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.62 |
| Alpha | -17.45 |
| Character TTM | |
|---|---|
| Beta | -0.123 |
| Beta Downside | 0.270 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.21% |
| CAGR/Max DD | -0.06 |
EPS (Earnings per Share)
Revenue
Description: ACI Albertsons Companies March 04, 2026
Albertsons Companies, Inc. (ACI) is a US-based food and drug retailer. The company operates a large network of grocery stores, a common approach in the fragmented US grocery market, offering a variety of products including groceries, general merchandise, health and beauty items, and pharmacy services.
ACI also engages in food manufacturing and processing for its stores. Its operations span numerous banners across the country, a strategy often employed by large retailers to cater to diverse regional preferences. These banners include Albertsons, Safeway, and Jewel-Osco. The company also manages in-store pharmacies, fuel centers, and distribution networks, typical components of a vertically integrated retail business model. For further detailed analysis, consider exploring ValueRay.
Headlines to watch out for
- Grocery price inflation impacts consumer spending and margins
- Fuel sales fluctuate with oil prices and demand
- Pharmacy revenue tied to prescription volume and drug costs
- Supply chain disruptions increase operational expenses
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 870.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.27 > 1.0 |
| NWC/Revenue: -0.88% < 20% (prev -0.61%; Δ -0.27% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.98b > Net Income 870.0m |
| Net Debt (15.23b) to EBITDA (4.15b): 3.67 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (534.7m) vs 12m ago -8.46% < -2% |
| Gross Margin: 27.22% > 18% (prev 0.28%; Δ 2694 % > 0.5%) |
| Asset Turnover: 304.0% > 50% (prev 299.8%; Δ 4.27% > 0%) |
| Interest Coverage Ratio: 3.41 > 6 (EBITDA TTM 4.15b / Interest Expense TTM 464.6m) |
Altman Z'' 0.54
| A: -0.03 (Total Current Assets 7.10b - Total Current Liabilities 7.82b) / Total Assets 27.09b |
| B: 0.07 (Retained Earnings 1.94b / Total Assets 27.09b) |
| C: 0.06 (EBIT TTM 1.59b / Avg Total Assets 26.88b) |
| D: 0.08 (Book Value of Equity 2.02b / Total Liabilities 24.59b) |
| Altman-Z'' Score: 0.54 = B |
Beneish M -3.08
| DSRI: 1.07 (Receivables 1.02b/929.0m, Revenue 81.72b/79.93b) |
| GMI: 1.02 (GM 27.22% / 27.84%) |
| AQI: 0.95 (AQ_t 0.15 / AQ_t-1 0.16) |
| SGI: 1.02 (Revenue 81.72b / 79.93b) |
| TATA: -0.11 (NI 870.0m - CFO 3.98b) / TA 27.09b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of ACI shares?
As of March 10, 2026, the stock is trading at USD 17.23 with a total of 5,440,016 shares traded.
Over the past week, the price has changed by -2.66%, over one month by -5.12%, over three months by +0.88% and over the past year by -16.00%.
Over the past week, the price has changed by -2.66%, over one month by -5.12%, over three months by +0.88% and over the past year by -16.00%.
Is ACI a buy, sell or hold?
Albertsons Companies has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold ACI.
- StrongBuy: 5
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22 | 27.7% |
| Analysts Target Price | 22 | 27.7% |
ACI Fundamental Data Overview March 06, 2026
P/E Trailing = 11.1039
P/E Forward = 7.5358
P/S = 0.1149
P/B = 3.5989
P/EG = 1.5074
Revenue TTM = 81.72b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 4.15b USD
Long Term Debt = 8.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.34b USD (from shortTermDebt, last quarter)
Debt = 15.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.23b USD (from netDebt column, last quarter)
Enterprise Value = 24.63b USD (9.39b + Debt 15.43b - CCE 195.1m)
Interest Coverage Ratio = 3.41 (Ebit TTM 1.59b / Interest Expense TTM 464.6m)
EV/FCF = 11.85x (Enterprise Value 24.63b / FCF TTM 2.08b)
FCF Yield = 8.44% (FCF TTM 2.08b / Enterprise Value 24.63b)
FCF Margin = 2.54% (FCF TTM 2.08b / Revenue TTM 81.72b)
Net Margin = 1.06% (Net Income TTM 870.0m / Revenue TTM 81.72b)
Gross Margin = 27.22% ((Revenue TTM 81.72b - Cost of Revenue TTM 59.48b) / Revenue TTM)
Gross Margin QoQ = 27.45% (prev 27.00%)
Tobins Q-Ratio = 0.91 (Enterprise Value 24.63b / Total Assets 27.09b)
Interest Expense / Debt = 0.75% (Interest Expense 116.0m / Debt 15.43b)
Taxrate = 22.35% (84.4m / 377.7m)
NOPAT = 1.23b (EBIT 1.59b * (1 - 22.35%))
Current Ratio = 0.91 (Total Current Assets 7.10b / Total Current Liabilities 7.82b)
Debt / Equity = 6.17 (Debt 15.43b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = 3.67 (Net Debt 15.23b / EBITDA 4.15b)
Debt / FCF = 7.33 (Net Debt 15.23b / FCF TTM 2.08b)
Total Stockholder Equity = 3.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.24% (Net Income 870.0m / Total Assets 27.09b)
RoE = 28.54% (Net Income TTM 870.0m / Total Stockholder Equity 3.05b)
RoCE = 13.83% (EBIT 1.59b / Capital Employed (Equity 3.05b + L.T.Debt 8.42b))
RoIC = 11.05% (NOPAT 1.23b / Invested Capital 11.14b)
WACC = 2.43% (E(9.39b)/V(24.82b) * Re(5.46%) + D(15.43b)/V(24.82b) * Rd(0.75%) * (1-Tc(0.22)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.08%
[DCF] Terminal Value 86.74% ; FCFF base≈1.61b ; Y1≈1.68b ; Y5≈1.93b
[DCF] Fair Price = 81.94 (EV 57.34b - Net Debt 15.23b = Equity 42.11b / Shares 513.9m; r=5.90% [WACC]; 5y FCF grow 4.52% → 2.90% )
EPS Correlation: -73.76 | EPS CAGR: -51.93% | SUE: -4.0 | # QB: 0
Revenue Correlation: 13.61 | Revenue CAGR: 2.58% | SUE: -0.28 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.59 | Chg7d=-0.002 | Chg30d=-0.019 | Revisions Net=-6 | Analysts=18
EPS next Year (2027-02-28): EPS=2.30 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+7.2% | Growth Revenue=-0.4%
[Analyst] Revisions Ratio: -0.60 (2 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.1% (Discount Rate 7.9% - Earnings Yield 9.0%)
[Growth] Growth Spread = +1.6% (Analyst 0.5% - Implied -1.1%)
P/E Forward = 7.5358
P/S = 0.1149
P/B = 3.5989
P/EG = 1.5074
Revenue TTM = 81.72b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 4.15b USD
Long Term Debt = 8.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.34b USD (from shortTermDebt, last quarter)
Debt = 15.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.23b USD (from netDebt column, last quarter)
Enterprise Value = 24.63b USD (9.39b + Debt 15.43b - CCE 195.1m)
Interest Coverage Ratio = 3.41 (Ebit TTM 1.59b / Interest Expense TTM 464.6m)
EV/FCF = 11.85x (Enterprise Value 24.63b / FCF TTM 2.08b)
FCF Yield = 8.44% (FCF TTM 2.08b / Enterprise Value 24.63b)
FCF Margin = 2.54% (FCF TTM 2.08b / Revenue TTM 81.72b)
Net Margin = 1.06% (Net Income TTM 870.0m / Revenue TTM 81.72b)
Gross Margin = 27.22% ((Revenue TTM 81.72b - Cost of Revenue TTM 59.48b) / Revenue TTM)
Gross Margin QoQ = 27.45% (prev 27.00%)
Tobins Q-Ratio = 0.91 (Enterprise Value 24.63b / Total Assets 27.09b)
Interest Expense / Debt = 0.75% (Interest Expense 116.0m / Debt 15.43b)
Taxrate = 22.35% (84.4m / 377.7m)
NOPAT = 1.23b (EBIT 1.59b * (1 - 22.35%))
Current Ratio = 0.91 (Total Current Assets 7.10b / Total Current Liabilities 7.82b)
Debt / Equity = 6.17 (Debt 15.43b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = 3.67 (Net Debt 15.23b / EBITDA 4.15b)
Debt / FCF = 7.33 (Net Debt 15.23b / FCF TTM 2.08b)
Total Stockholder Equity = 3.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.24% (Net Income 870.0m / Total Assets 27.09b)
RoE = 28.54% (Net Income TTM 870.0m / Total Stockholder Equity 3.05b)
RoCE = 13.83% (EBIT 1.59b / Capital Employed (Equity 3.05b + L.T.Debt 8.42b))
RoIC = 11.05% (NOPAT 1.23b / Invested Capital 11.14b)
WACC = 2.43% (E(9.39b)/V(24.82b) * Re(5.46%) + D(15.43b)/V(24.82b) * Rd(0.75%) * (1-Tc(0.22)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.08%
[DCF] Terminal Value 86.74% ; FCFF base≈1.61b ; Y1≈1.68b ; Y5≈1.93b
[DCF] Fair Price = 81.94 (EV 57.34b - Net Debt 15.23b = Equity 42.11b / Shares 513.9m; r=5.90% [WACC]; 5y FCF grow 4.52% → 2.90% )
EPS Correlation: -73.76 | EPS CAGR: -51.93% | SUE: -4.0 | # QB: 0
Revenue Correlation: 13.61 | Revenue CAGR: 2.58% | SUE: -0.28 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.59 | Chg7d=-0.002 | Chg30d=-0.019 | Revisions Net=-6 | Analysts=18
EPS next Year (2027-02-28): EPS=2.30 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+7.2% | Growth Revenue=-0.4%
[Analyst] Revisions Ratio: -0.60 (2 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.1% (Discount Rate 7.9% - Earnings Yield 9.0%)
[Growth] Growth Spread = +1.6% (Analyst 0.5% - Implied -1.1%)